CDC offers new ‘Prevent Group B Strep’ app for smartphones
Group B Streptococcus (GBS), or Streptococcus agalactiae, remains the leading cause of early onset neonatal sepsis in the United States. Image/CDC Now the Centers for Disease Control and Prevention (CDC) has announced More...
Quidel Receives FDA Clearance for the sale of its AmpliVue Group B Strep Assay
PRESS RELEASE Quidel Corporation, a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has received 510(k) clearance from the United More...
